The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus.
Open accessAbstract
An unknown environmental agent has been suspected to induce systemic lupus erythematosus (lupus) in man. Prompted by our recent immunochemical findings, we sought evidence for an association between Epstein-Barr virus infection and lupus. Because the vast majority of adults have been infected with Epstein-Barr virus, we chose to study children and young adults. Virtually all (116 of 117, or 99%) of these young patients had seroconverted against Epstein-Barr virus, as compared with only 70% (107 of 153) of their controls (odds ratio 49.9, 95% confidence interval 9.3-1025, P < 0. 00000000001). The difference in the rate of Epstein-Barr virus seroconversion could not be explained by serum IgG level or by cross-reacting anti-Sm/nRNP autoantibodies. No similar difference was found in the seroconversion rates against four other herpes viruses. An assay for Epstein-Barr viral DNA in peripheral blood lymphocytes established Epstein-Barr virus infection in the peripheral blood of all 32 of the lupus patients tested, while only 23 of the 32 matched controls were infected (odds ratio > 10, 95% confidence interval 2.53-infinity, P < 0.002). When considered with other evidence supporting a relationship between Epstein-Barr virus and lupus, these data are consistent with, but do not in themselves establish, Epstein-Barr virus infection as an etiologic factor in lupus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
A novel form of Epstein-Barr virus latency in normal B cells in vivo
Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. H., & Thorley-Lawson, D. A. (1995) · Cell · doi:10.1016/0092-8674(95)90513-8 · Cited by 1,593
Strasser, A., Whittingham, S., Vaux, D. L., Bath, M. L., Adams, J. M., Cory, S., & Harris, A. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8661 · Cited by 862
Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., & Masucci, M. G. (1995) · Nature · doi:10.1038/375685a0 · Cited by 823
Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G., & Rickinson, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8479 · Cited by 600
Lerner, M. R., Andrews, N. C., Miller, G., & Steitz, J. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.805 · Cited by 575
Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis
Gregory, C. D., Dive, C., Henderson, S., Smith, C. A., Williams, G. T., Gordon, J., & Rickinson, A. B. (1991) · Nature · doi:10.1038/349612a0 · Cited by 506
Saito, I., Servenius, B., Compton, T., & Fox, R. I. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.6.2191 · Cited by 424
Cited by
Rahman, A., & Isenberg, D. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra071297 · Cited by 1,632
The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley, J. B., Alarcón-Riquelme, M. E., Criswell, L. A., Jacob, C. O., Kimberly, R. P., Moser, K. L., Tsao, B. P., Vyse, T. J., & Langefeld, C. D. (2008) · Nature Genetics · doi:10.1038/ng.81 · Cited by 1,309
“SLE predominantly affects women (at a 9:1 ratio), particularly during childbearing years, and has strong genetic and environmental component”
BackgroundSelf-citationMolecular mimicry and autoimmunity
Rojas, M., Restrepo-Jiménez, P., Monsalve, D. M., Pacheco, Y., Acosta-Ampudia, Y., Ramírez-Santana, C., Leung, P. S. C., Ansari, A. A., Gershwin, M. E., & Anaya, J.-M. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.012 · Cited by 627
The Immunology of Epstein-Barr Virus–Induced Disease
Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B., & Hislop, A. D. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112326 · Cited by 602
Detecting shared pathogenesis from the shared genetics of immune-related diseases
Zhernakova, A., van Diemen, C. C., & Wijmenga, C. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2489 · Cited by 551
Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis
Thacker, E. L., Mirzaei, F., & Ascherio, A. (2006) · Annals of Neurology · doi:10.1002/ana.20820 · Cited by 517
Moser, K. L., Neas, B. R., Salmon, J. E., Yu, H., Gray-McGuire, C., Asundi, N., Bruner, G. R., Fox, J., Kelly, J., Henshall, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14869 · Cited by 449
Self-citationEarly events in lupus humoral autoimmunity suggest initiation through molecular mimicry
McClain, M. T., Heinlen, L. D., Dennis, G. J., Roebuck, J., Harley, J. B., & James, J. A. (2005) · Nature Medicine · doi:10.1038/nm1167 · Cited by 441
Self-citationTranscription factors operate across disease loci, with EBNA2 implicated in autoimmunity
Harley, J. B., Chen, X., Pujato, M., Miller, D., Maddox, A., Forney, C., Magnusen, A. F., Lynch, A., Chetal, K., Yukawa, M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0102-3 · Cited by 406
Self-citationPathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
Crow, M. K. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223741 · Cited by 398
Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure
James, J. A., Neas, B. R., Moser, K. L., Hall, T., Bruner, G. R., Sestak, A. L., & Harley, J. B. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1122::aid-anr193>3.0.co;2-d · Cited by 390
Self-citationThe genetics of complex autoimmune diseases: non-MHC susceptibility genes
Wanstrat, A., & Wakeland, E. (2001) · Nature Immunology · doi:10.1038/ni0901-802 · Cited by 383
Oxidative stress in the pathology and treatment of systemic lupus erythematosus
Perl, A. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.147 · Cited by 358
Pathogenesis of human systemic lupus erythematosus: recent advances
Crispín, J. C., Liossis, S.-N. C., Kis-Toth, K., Lieberman, L. A., Kyttaris, V. C., Juang, Y.-T., & Tsokos, G. C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.12.005 · Cited by 359
Cigarette smoking and the risk of systemic lupus erythematosus: A meta‐analysis
Costenbader, K. H., Kim, D. J., Peerzada, J., Lockman, S., Nobles‐Knight, D., Petri, M., & Karlson, E. W. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20049 · Cited by 333
EBV Persistence—Introducing the Virus
Thorley-Lawson, D. A. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-22822-8_8 · Cited by 333
Vaccination and Autoimmunity—‘vaccinosis’: A Dangerous Liaison?
Y, S., & A, A.-M. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0346 · Cited by 302
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus
Poole, B. D., Scofield, R. H., Harley, J. B., & James, J. A. (2006) · Autoimmunity · doi:10.1080/08916930500484849 · Cited by 286
Self-citationInfection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases
Pender, M. P. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.005 · Cited by 285
Epstein-Barr Virus in Pediatric Multiple Sclerosis
Alotaibi, S. (2004) · JAMA · doi:10.1001/jama.291.15.1875 · Cited by 280
Epstein–Barr virus in autoimmune diseases
Toussirot, É., & Roudier, J. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2008.09.007 · Cited by 278
Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus
Kang, I., Quan, T., Nolasco, H., Park, S.-H., Hong, M. S., Crouch, J., Pamer, E. G., Howe, J. G., & Craft, J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1287 · Cited by 275
Anti-Sm and anti-RNP antibodies
Migliorini, P., Baldini, C., Rocchi, V., & Bombardieri, S. (2005) · Autoimmunity · doi:10.1080/08916930400022715 · Cited by 272
Balfour, H. H., Sifakis, F., Sliman, J. A., Knight, J. A., Schmeling, D. O., & Thomas, W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit321 · Cited by 266
Minireview: glucocorticoids in autoimmunity: unexpected targets and mechanisms
Flammer, J. R., & Rogatsky, I. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-0068 · Cited by 140
Endogenous retroviral pathogenesis in lupus
Perl, A., Fernandez, D., Telarico, T., & Phillips, P. E. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833c6297 · Cited by 75
Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE
Perl, A., Nagy, G., Koncz, A., Gergely, P., Fernandez, D., Doherty, E., Telarico, T., Bonilla, E., & Phillips, P. E. (2008) · Autoimmunity · doi:10.1080/08916930802024764 · Cited by 58
Metadata
- Authors
- James, J. A., Kaufman, K. M., Farris, A. D., Taylor-Albert, E., Lehman, T. J., & Harley, J. B.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-12-15
- Volume
- 100
- Issue
- 12
- Pages
- 3019-3026
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2020689018
- Cited by
- 522
- References
- 21
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.